Droperidol inhibits cardiac vagal efferents in dogs.

Standard

Droperidol inhibits cardiac vagal efferents in dogs. / Nashan, Björn; Inoue, K; Arndt, J O.

in: BRIT J ANAESTH, Jahrgang 56, Nr. 11, 11, 1984, S. 1259-1266.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Nashan B, Inoue K, Arndt JO. Droperidol inhibits cardiac vagal efferents in dogs. BRIT J ANAESTH. 1984;56(11):1259-1266. 11.

Bibtex

@article{3869f404aba54ad6baa3a4d07ea8b3ce,
title = "Droperidol inhibits cardiac vagal efferents in dogs.",
abstract = "The action of droperidol on cardiac vagal efferents was studied in anaesthetized dogs. Droperidol in cumulative doses (0.125, 0.25 and 0.5 mg kg-1 i.v.) inhibited cardiac vagal discharge, shifted pressure-response curves to lower activities, increased heart rate, and decreased arterial pressure slightly. The effects on vagal discharge and heart rate reached their maxima at 0.25 mg kg-1 as a further increase in the dose had no additional effect. The vagal inhibition and the tachycardia were independent of arterial pressure as indicated by the shift in the pressure-response curves and by the fact that they also occurred when the decrease in arterial pressure was prevented. After pretreatment with atropine, droperidol had no effect on heart rate. Thus, droperidol inhibits central vagal drive independently of arterial pressure. This central vagolytic action seems to be the main cause for the positive chronotropic effect of droperidol.",
author = "Bj{\"o}rn Nashan and K Inoue and Arndt, {J O}",
year = "1984",
language = "Deutsch",
volume = "56",
pages = "1259--1266",
journal = "BRIT J ANAESTH",
issn = "0007-0912",
publisher = "Oxford University Press",
number = "11",

}

RIS

TY - JOUR

T1 - Droperidol inhibits cardiac vagal efferents in dogs.

AU - Nashan, Björn

AU - Inoue, K

AU - Arndt, J O

PY - 1984

Y1 - 1984

N2 - The action of droperidol on cardiac vagal efferents was studied in anaesthetized dogs. Droperidol in cumulative doses (0.125, 0.25 and 0.5 mg kg-1 i.v.) inhibited cardiac vagal discharge, shifted pressure-response curves to lower activities, increased heart rate, and decreased arterial pressure slightly. The effects on vagal discharge and heart rate reached their maxima at 0.25 mg kg-1 as a further increase in the dose had no additional effect. The vagal inhibition and the tachycardia were independent of arterial pressure as indicated by the shift in the pressure-response curves and by the fact that they also occurred when the decrease in arterial pressure was prevented. After pretreatment with atropine, droperidol had no effect on heart rate. Thus, droperidol inhibits central vagal drive independently of arterial pressure. This central vagolytic action seems to be the main cause for the positive chronotropic effect of droperidol.

AB - The action of droperidol on cardiac vagal efferents was studied in anaesthetized dogs. Droperidol in cumulative doses (0.125, 0.25 and 0.5 mg kg-1 i.v.) inhibited cardiac vagal discharge, shifted pressure-response curves to lower activities, increased heart rate, and decreased arterial pressure slightly. The effects on vagal discharge and heart rate reached their maxima at 0.25 mg kg-1 as a further increase in the dose had no additional effect. The vagal inhibition and the tachycardia were independent of arterial pressure as indicated by the shift in the pressure-response curves and by the fact that they also occurred when the decrease in arterial pressure was prevented. After pretreatment with atropine, droperidol had no effect on heart rate. Thus, droperidol inhibits central vagal drive independently of arterial pressure. This central vagolytic action seems to be the main cause for the positive chronotropic effect of droperidol.

M3 - SCORING: Zeitschriftenaufsatz

VL - 56

SP - 1259

EP - 1266

JO - BRIT J ANAESTH

JF - BRIT J ANAESTH

SN - 0007-0912

IS - 11

M1 - 11

ER -